Sanya Sukduang has 20+ years of experience litigating life sciences patent disputes, including cases involving Hatch-Waxman Abbreviated New Drug Application (ANDA) challenges for brand drug manufacturers, biological products and medical devices. Drawing from his extensive litigation experience, Sanya also advises clients on an array of pre-litigation and acquisition due diligence investigations, as well as strategic patent portfolio planning.

Download full bio 


  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

[Sanya] has great vision and a disarming personality – as opposing counsel, you might not notice what ‘litigation thing’ he is doing to you. – Intellectual Asset Management Patent 1000

  • Washington College of Law American University
    JD, cum laude, 1999

  • Boston College
    BS, Biology

Admissions & Credentials

District of Columbia


U.S. Patent and Trademark Office


  • American Intellectual Property Law Association

  • National Asian Pacific American Bar Association

  • Thai American Bar Association

Rankings & Accolades

    LMG Life Sciences: Shortlisted for General Patent Litigator of the Year – DC Metro (2016, 2017, 2021)

    The Legal 500 US: Healthcare: Life Sciences (2021)

    The Legal 500 US: Patents: Litigation (2021)

    IAM Media: IAM Patent 1000 List for Patent Litigation (2018 – 2020)

    LMG Life Sciences: Life Science Star – Intellectual Property (2012 – 2021)

    Managing Intellectual Property: Shortlisted for Outstanding Litigator: District of Columbia (2017)

    National Asian Pacific American Bar Association: Best Lawyers Under 40 (2013)

    Eli Lilly and Company: Quality Advocate Award (2011)